Company: INVUP
Filing Date: 2025-08-13
Form Type: 10-Q
Source: 0001493152-25-011912
Chunk: 121

Company: Investview, Inc.
Filing Date: 2025-08-13
Form: 10-Q
Item: Part I, Item 8
Chunk 121
---
  
    Bank interest 
     100,535  
     28,875 
  
    Event ticket sales 
     52,673  
     350,635 
  
    Leasing income 
     126,489  
     300,248 
  
    All other, net 
     (182) 
     (31,312)

    Net income (loss) before income taxes 
    $(248,575) 
    $2,971,929 

    [1]
    Other
    profit (loss) is attributable to corporate and nonoperating segment expenses, and is therefore not included in the total for segment
    gross profit (loss).

NOTE
13 – ACQUISITION

On
October 11, 2024, Renu Laboratories LLC (a wholly owned subsidiary of myLife Wellness Company which is a wholly owned subsidiary of Investview,
Inc.) closed on the purchase of the business and assets of Renu Labs, Inc. (“Seller”), along with a 100% ownership interest
in Goldman’s Pharmaceuticals LLC and a 50% ownership interest in ELRT Technologies, LLC (together known as “Renu Labs”)
from Gregg Hanson. Renu Labs is a manufacturer of proprietary and other health, beauty and wellness products. The total purchase price
of Renu Labs was $1,780,000.

The
transaction was accounted for as a business combination using the acquisition method of accounting in accordance with the ASC Topic 805,
Business Combination. The following table summarizes the purchase accounting for the fair value of the assets acquired and liabilities
assumed at the date of the acquisition:

 SCHEDULE
OF FAIR VALUE OF ASSETS ACQUIRED AND LIABILITIES ASSUMED AT DATE OF ACQUISITION

    Cash 
    $1,495 
  
    Customer deposits – intercompany 
     7,360 
  
    Domain names [1] 
     40,310 
  
    Raw materials 
     149,260 
  
    Manufacturing equipment 
     717,020 
  
    Total assets acquired 
    $915,445 

    Accounts payable 
    $323 
  
    Customer deposits 
     572,386 
  
    Total liabilities assumed 
    $572,709 

    Net assets acquired 
     342,736 

    Consideration [2] 
    $1,207,614 
  
    Fair value of noncontrolling interest in ELRT Technologies, LLC